Atlas Trials

Endostar Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy for Locoregional Nasopharyngeal Carcinoma

Clinical trial NCT03932266 · UNKNOWN

Trial details

NCT number
NCT03932266
Sponsor
Jiangsu Cancer Institute & Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma
Start date
2019-06-01
Primary completion
2022-09-01
Enrollment
73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.